99% Savings - Buy Just @1 Rs X
Tenofovir + Emtricitabine is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Tenofovir + Emtricitabine is used -
Moderate
Mild
Is the use of Tenofovir + Emtricitabine safe for pregnant women?
Tenofovir + Emtricitabine is safe for pregnant women.
Is the use of Tenofovir + Emtricitabine safe during breastfeeding?
Tenofovir + Emtricitabine is completely safe for breastfeeding women.
What is the effect of Tenofovir + Emtricitabine on the Kidneys?
Tenofovir + Emtricitabine may have mild side effects on the kidneys.
What is the effect of Tenofovir + Emtricitabine on the Liver?
Tenofovir + Emtricitabine has very mild side effects on the liver.
What is the effect of Tenofovir + Emtricitabine on the Heart?
Using Tenofovir + Emtricitabine does not have any harmful effects on the heart.
Tenofovir + Emtricitabine should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tenofovir + Emtricitabine unless your doctor advises you to do so -
Is this Tenofovir + Emtricitabine habit forming or addictive?
Tenofovir + Emtricitabine is not addictive in nature.
Interaction between Food and Tenofovir + Emtricitabine
You can take Tenofovir + Emtricitabine with food.
Interaction between Alcohol and Tenofovir + Emtricitabine
Consuming Tenofovir + Emtricitabine with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1179
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 803-804
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Viread® (tenofovir disoproxil fumarate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Emtriva®(emtricitabine)